www.ieecps.org, www.ices.net.in

 

This is a 4-8week program to achieve a healthy, strong and well perfused heart. 

Dr Krishnaveni is professionally trained and certified to treat and manage patients under the patronage of Dr Ramasamy, Cardiologist, The International EECP and International Cardiology EECP /ECP Societies

 

It is an FDA approved cardiac rehabilitative treatment program for Individuals with pre-existing Ischemic heart conditions, before or after invasive and surgical procedures like Angioplasty and Coronary Artery Bypass Graft. It has been widely studied the United States of America, China and India. 

​

Individuals with blockages in their coronary arteries will eventually weaken their heart muscle as well.  This program includes a thorough assessment of the heart including fresh blood tests, radiology report review, dietary/ lifestyle habits and EECP (enhanced external counter pulsation therapy) to improve perfusion and energy to the heart. Your heart is a muscle. Just like the biceps, the more you work your heart, the bigger and stronger it gets. Over time, your heart works more efficiently and can push out a greater volume of blood with every beat.

 

Enhanced External Counterpulsation and Future Directions

Step Beyond Medical Management for Patients With Angina and Heart Failure

Aarush Manchanda, MD,* Ozlem Soran, MD, MPH, FACC, FESC†

Washington, DC; and Pittsburgh, Pennsylvania.

ABSTRACT

​

The technique of counterpulsation, studied for almost one-half century now, is considered a safe, highly beneficial, low-cost, noninvasive treatment for these angina patients, and now for heart failure patients as well. Recent evidence suggests that enhanced external counterpulsation (EECP) therapy may improve symptoms and decrease long-term morbidity via more than 1 mechanism, including improvement in endothelial function, promotion of collateralization, enhancement of ventricular function, improvement in oxygen consumption (VO2), regression of atherosclerosis, and peripheral training effects similar to exercise.

Numerous clinical trials in the last 2 decades have shown EECP therapy to be safe and effective for patients with refractory angina with a clinical response rate averaging 70% to 80%, which is sustained up to 5 years. It is not only safe in patients with coexisting heart failure, but also is shown to improve quality of life and exercise capacity and to improve left ventricular function long-term. Interestingly, EECP therapy has been studied for various potential uses other than heart disease, such as restless leg syndrome, sudden deafness, hepatorenal syndrome, erectile dysfunction, and so on.

​

This review summarizes the current evidence for its use in stable angina and heart failure and its future directions.

(J Am Coll Cardiol 2007;50:1523–31) © 2007 by the American College of Cardiology Foundation.

​

The Role of Enhanced External Counter Pulsation Therapy in Clinical Practice

Umesh Sharma, MD, FACP,* Heidi K. Ramsey, BS, RCEP,† and Tahir Tak, MD, PhD, FACC

ABSTRACT

​

Enhanced external counterpulsation (EECP) has been approved by the United States Food and Drug Administration (FDA) for management of refractory angina (Class IIb). EECP uses three sets of pneumatic cuffs that sequentially contract during diastole, increasing aortic diastolic pressure, augmenting coronary blood flow and central venous return.

EECP improves anginal symptoms and exercise tolerance, and reduces nitroglycerin use in patients with chronic, stable angina. EECP has also been shown to be safe and beneficial in patients with symptomatic stable congestive heart failure. 

Clin Med Res. 2013 Dec; 11(4): 226–232.

doi: 10.3121/cmr.2013.1169

​

PRIMARY GOALS OF POWER YOUR HEART PROGRAM

​